Booster shot of Covaxin neutralises both Omicron and Delta variants of Sars-CoV-2 virus, Bharat Biotech said on Wednesday.
The company said that Covaxin (BBV152) booster dose generated ‘robust neutralising antibody responses’ against both Omicro (B.1.529) and Delta (B.1.617.2) using a live virus neutralisation assay (test). It added that 100 percent of the test serum samples showed neutralisation of the Delta variant, and more than 90 percent of the samples showed neutralisation of the Omicron variant.
The company today announced results from a study conducted at Emory University demonstrating that sera from subjects who received a booster dose of Covaxin (BBV152)